Despite uncertainty around HPV vaccine sales in China, Merck CEO Rob Davis said he’s confident the company can “deliver strong growth” and navigate Keytruda’s impending …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Vireo Growth Inc. Announces Closing of Oversubscribed US$81 Million Equity Securities Offering – Oversubscribed equity raise at US$0.625 per share capitalizes Company with a strong
Michelle Bean is drowning in batteries she doesn’t need. For two years, the batteries and electrode pads arrived each month at her home in West
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes